Fig. 5From: Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathologyTriple fluorescent stainings of CK2α/α’, amyloid fibrils and astrocytes in temporal cortex and hippocampus of AD patients. Shown are representative immunohistochemical stainings for CK2α/α’ of the mid-temporal cortex (a–d, Braak stage VI, Table 1C case #43) and hippocampus (e–h, Braak stage VI, Table 1C case #42) of two AD patients. a, e CK2α/α’ immunoreactivity, b, f amyloid fibrils (Thioflavin) and c, g astrocytes (GFAP) in the temporal cortex (a–d, Braak stage VI, Table 1C case #43) and hippocampus (e–h, Braak stage VI, Table 1C case #42) of AD patients. Immunofluorescent detection was performed using CKα/α’ (red), amyloid fibrils (green) and astrocytes (GFAP) (blue). Scale bars A–H 50 μmBack to article page